| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/28/2004 | EP1441032A1 Methods of assaying receptor activity and constructs useful in such methods |
| 07/28/2004 | EP1441031A1 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same |
| 07/28/2004 | EP1441030A1 Method of purifying recombinant fused protein and method of producing protein using the same |
| 07/28/2004 | EP1441029A1 Human cell lines |
| 07/28/2004 | EP1441011A1 Energy transfer dye containing an aromatic-substituted xanthene dye as donor dye and/or acceptor dye |
| 07/28/2004 | EP1440982A2 Ifn-thy fusion protein, dna coding therefore, its preparation and application |
| 07/28/2004 | EP1440981A2 Full-length human cdna |
| 07/28/2004 | EP1440317A2 Microfluidic ser(r)s detection |
| 07/28/2004 | EP1440311A2 Affinity-shifted probes for quantifying analyte polynucleotides |
| 07/28/2004 | EP1440167A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319 |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440165A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/28/2004 | EP1440164A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440162A2 Detection of predisposition to osteoporosis |
| 07/28/2004 | EP1440161A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 07/28/2004 | EP1440159A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/28/2004 | EP1440157A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2004 | EP1440156A2 Antigens and vectors for vaccination |
| 07/28/2004 | EP1440155A2 Lipase variants |
| 07/28/2004 | EP1440154A2 Production of oil with higher erucic acid content |
| 07/28/2004 | EP1440153A1 Manipulation of starch granule size and number |
| 07/28/2004 | EP1440152A2 5t4 ligand |
| 07/28/2004 | EP1440151A2 Seed specific 7s alpha promoter for expressing genes in plants |
| 07/28/2004 | EP1440150A2 Pyranosone dehydratase from phanerochaete chrysosporium |
| 07/28/2004 | EP1440149A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
| 07/28/2004 | EP1440146A1 Gene targeting methods and vectors |
| 07/28/2004 | EP1440145A1 Fungal micro-organism having an increased ability to carry out biotechnological process(es) |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440087A2 Mycobacterial genes down-regulated during latency |
| 07/28/2004 | EP1440085A2 Transient immortalization of cells by oncogenic proteins or telomerase |
| 07/28/2004 | EP1440084A2 Sperm factor sequences |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440081A2 Beta 2 adrenergic polymorphism detection |
| 07/28/2004 | EP1440080A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 07/28/2004 | EP1440079A1 Acyclic linker-containing oligonucleotides and uses thereof |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439852A1 Peptides and related compounds having thrombopoietic activity |
| 07/28/2004 | EP1392111A4 Method for targeting transcriptionally active loci |
| 07/28/2004 | EP1311660A4 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 07/28/2004 | EP1261697B1 Cold-active beta galactosidase, the process for its preparation and the use thereof |
| 07/28/2004 | EP1238095A4 Compositions and methods for caspase-induced apoptosis |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1216255B1 Method for nucleic acid isolation and kit |
| 07/28/2004 | EP1179056B1 Mixed-bed solid phase and its use in the isolation of nucleic acids |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP1154991B1 Salicylamide-lanthanide complexes for use as luminescent markers |
| 07/28/2004 | EP1115883B1 Method for obtaining human skin dna samples with an adhesive sheet |
| 07/28/2004 | EP1078085B1 Use of a polypeptide derived from a pa1b legume albumen as insecticide |
| 07/28/2004 | EP1047781B1 Il-18 receptors |
| 07/28/2004 | EP1028739B1 Use of protein h as cytostatic agent |
| 07/28/2004 | EP1012341A4 An alpha-2 macroglobulin diagnostic test |
| 07/28/2004 | EP0981651B1 Detection of retroviral subtypes based upon envelope specific sequences |
| 07/28/2004 | EP0977869B1 Lipase and use of same for improving doughs and baked products |
| 07/28/2004 | EP0941311B1 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
| 07/28/2004 | EP0938501B1 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| 07/28/2004 | EP0935607B1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 07/28/2004 | EP0920536B1 Procedure for subtractive hybridization and difference analysis |
| 07/28/2004 | EP0920509B1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0879299B1 High density array fabrication and readout method for a fiber optic biosensor |
| 07/28/2004 | EP0839911B1 Method for identifying attenuated varicella virus oka strain or a strain derived therefrom |
| 07/28/2004 | EP0752884B1 Method of treating auto-immune diseases using type one interferons |
| 07/28/2004 | EP0728214B1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 07/28/2004 | EP0719332B1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/28/2004 | EP0584214B1 Gene manipulation and expression using genomic elements |
| 07/28/2004 | EP0452484B2 Production of proteins using homologous recombination |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516738A Acetylation of GP41 framgnets |
| 07/28/2004 | CN1516736A Transgenic plants with reduced adenylate kinase activity showing increased accumulation of starch |
| 07/28/2004 | CN1516735A Method to generate non-virulent microorganism from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 07/28/2004 | CN1516734A Transformed silkworm producing human collagen |
| 07/28/2004 | CN1516706A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/28/2004 | CN1516597A Diagnostic indicator of thymic function |
| 07/28/2004 | CN1515680A Application of ion channel inhibitor for curing arhythmia |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515671A Agrobacterium mediated plant nonselective gene conversion and nonselective marker gene conversion method |
| 07/28/2004 | CN1515668A Preparation process of enzyme preparation |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1515590A Erythropoietin conjugate |
| 07/28/2004 | CN1515588A Biological function of human testis specific gene HSD-3,8 coded protein |
| 07/28/2004 | CN1515541A Method for detecting ligand pair combination by using non-fluorescent marker and its composite |
| 07/28/2004 | CN1159585C Method for determining leptin |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159457C DNA Sequencing method |
| 07/28/2004 | CN1159456C Method of screening genovariant and protein combining DNA segment |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159452C Method and compositions for detecting binding of ligand pair using non-fluorescent label |
| 07/28/2004 | CN1159450C Low oxygen affinity mutant hemoglobin |
| 07/28/2004 | CN1159446C Fish electric pulse sperm transgene method |
| 07/28/2004 | CN1159445C Recombinant adevovirus for tissue specifie expression in heart |
| 07/28/2004 | CN1159444C Mutated penicilling acylase genes |
| 07/28/2004 | CN1159443C Method for producing L-lysine |
| 07/28/2004 | CN1159442C Novel stranis of bacillus subtilis group for food fermentation |
| 07/28/2004 | CN1159441C USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159439C Pantropic neurotrophic factors |
| 07/28/2004 | CN1159436C Ensyme with aminopeptidase activity |
| 07/28/2004 | CN1159341C Method of treatment of corticosteroid induced osteopenia |